Scope

pMedGR aims at supporting research and innovation towards next generation healthcare applications. Specifically, the infrastructure aims at re-designing ongoing and prospective clinical trials, linking them with molecular profiles obtained through high-throughput ‘omics’ technologies towards more efficient and cost-effective health and disease management for European citizens.

pMedGR offers a unique opportunity for obtaining real added value for the European and regional social market economy and has a high potential for attracting private investments, maximizing synergies between national and EU funding schemes and thus mobilizing, leveraging and bundling different types of public and private funding. It combines economic viability with high-socioeconomic returns in the area of healthcare management and brings together the industrial sector, clinicians, medical researchers, biomedical scientists and technology experts, thus providing the necessary means to initiate and develop innovation.